Shares of iSpecimen gained after securing suppliers for the flu-like human metapneumovirus, a virus which causes upper respiratory infections. The stock rose 22%, to $3.50, in after-hours trading ...

Biden is not releasing bird flu vaccines prior to leaving office. This is a risky gamble. You’re reading The Checkup With Dr.

President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines ...

CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...

Maryland may be known for crabs, but it is also a major producer of broiler chickens and dairy products. So a recent spate of ...

Trump's pick for health secretary has a record of attacking vaccines. In fact he's even taken direct aim at bird flu shots.

The COVID mRNA vaccine generates enough of an antibody response to protect against severe disease for six months. But other ...

The U.S. has developed a bird flu vaccine that can be prepared when needed. It’s not currently available because health ...

On Monday, the U.S. Centers for Disease Control and Prevention (“CDC”) reported the first human death in the country from the H5N1 virus, also known as bird flu. Despite the death, CDC believes that ...

Genetic sequences of H5N1 bird flu viruses collected from a person in ... who works at the University of Saskatchewan’s Vaccine and Infectious Disease Organization in Saskatoon, Canada, said ...

Jefferies sees Arbutus (NASDAQ:ABUS) potentially benefitting from vaccines being developed by Moderna (MRNA) and Pfizer (PFE) ...

to develop a similar vaccine using mRNA technology against H5N1. The C.D.C. has also ramped up testing and surveillance of the pathogen, and has contracted with commercial manufacturers to make ...